Showing results (1311-1320 of 1,400) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|April 11, 2024
NF1-Driven Rhabdomyosarcoma Phenotypes: A Comparative Clinical and Molecular Study of NF1-Mutant Rhabdomyosarcoma and NF1-Associated Malignant Triton TumorHenry de Traux de Wardin, Josephine K Dermawan, Fabio Vanoli, et al.
JCO Precision Oncology|January 23, 2026
Identification of Predictive Genomic Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis of Real-World Clinicogenomic DataMimma Rizzo, Gaetano Pezzicoli, Camilla Porta, et al.
JCO Precision Oncology|January 15, 2026
Comprehensive Genomic Profiling of Advanced Anal Adenocarcinoma in JapanNozomu Ogura, Hidekazu Hirano, Kouya Shiraishi, et al.
JCO Precision Oncology|January 15, 2026
Olaparib in Patients With Solid Tumors With ATM Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyDaniel R Carrizosa, Michael Rothe, Pam K Mangat, et al.
JCO Precision Oncology|January 15, 2026
Assessing the Value of Sequential Next-Generation Sequencing and Multiple Molecular Tumor Board Reviews for Patients With Solid-Tumor MalignanciesAllison L Swiecki-Sikora, Lydia Williams, Ning Li, et al.
JCO Precision Oncology|January 15, 2026
Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder AnalysisSusanne A Gatz, Julia Glade-Bender, Andrew D J Pearson, et al.
JCO Precision Oncology|January 14, 2026
Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With BRAFV600E Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol HApril K S Salama, Victoria Wang, Erin R Macrae, et al.
JCO Precision Oncology|February 13, 2026
Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in Patients With Advanced-Stage MelanomaVincent T Ma, Alice Y Zhou, Amir Forati, et al.
JCO Precision Oncology|February 6, 2026
Modeling Individual-Level Uncertainty From Missing Data in Multifactorial Breast Cancer Risk PredictionBethan L White, Lorenzo Ficorella, Xin Yang, et al.
JCO Precision Oncology|December 10, 2025
Neoadjuvant Immunotherapy With Prolgolimab in Patients With Locally Advanced Microsatellite Instability/Defective Mismatch Repair Colorectal CancerOlesya Kuznetsova, Albina Zagidullina, Natalia Drobot, et al.
Pageof 140